Peter Holleman
28-09-2021
The complete DNA test allows for personalized treatment and so limits the chance of undesirable side effects.
Back to newsMore news
First time linking Hartwig Medical Database with the Netherlands Cancer Registry for AYA Patients
16-07-2025
This July, the first data transfer was completed between the Netherlands Cancer Registry (NKR) and the Hartwig Medical Database for …
GLOW: working toward more treatment options for glioblastoma
23-05-2023
The outlook for patients with glioblastoma has been unfavorable for years, and treatment options remain limited. That is a reason …
Breast cancer awareness month
30-09-2024
October is the international breast cancer awareness month. Breast cancer is the second most common type of cancer, and the …
Personalised selection of experimental treatment in patients with advanced solid cancer is feasible using whole-genome sequencing.
AIOS Internal Medicine, PhD candidate Erasmus MC